Basis of Presentation and Significant Accounting Policies - Schedule of Revenues consist of product sales to customers (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Total revenues	$ 250,401	$ 211,699	$ 698,195	$ 495,396
NUPLAZID
Disaggregation of Revenue [Line Items]
Total revenues	159,186	144,828	446,518	405,308
DAYBUE
Disaggregation of Revenue [Line Items]
Total revenues	$ 91,215	$ 66,871	$ 251,677	$ 90,088